Molecular Neurobiology
1 – 21 of 21
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparing the results from a Swedish pregnancy cohort using data from three automated placental growth factor immunoassay platforms intended for first-trimester preeclampsia prediction
(
- Contribution to journal › Article
- 2022
-
Mark
Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
The Effects of Optogenetic Activation of Astrocytes on Spike-and-Wave Discharges in Genetic Absence Epileptic Rats
(
- Contribution to journal › Article
- 2021
-
Mark
DNAJB6b is Downregulated in Synucleinopathies
(
- Contribution to journal › Article
-
Mark
DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Protein Quality Control Pathways at the Crossroad of Synucleinopathies
(
- Contribution to journal › Scientific review
-
Mark
Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation
(
- Contribution to journal › Article
- 2019
-
Mark
The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells
(
- Contribution to journal › Article
-
Mark
The lower expression of parvalbumin in the primary somatosensory cortex of WAG/Rij rats may facilitate the occurrence of absence seizures
(
- Contribution to journal › Article
- 2018
-
Mark
2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
(
- Contribution to journal › Article
- 2014
-
Mark
Skeletal muscle atrophy in r6/2 mice - altered circulating skeletal muscle markers and gene expression profile changes.
(
- Contribution to journal › Article
- 2013
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
- 2012
-
Mark
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
(
- Contribution to journal › Article
- 2011
-
Mark
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
(
- Contribution to journal › Article
- 2010
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
- 2009
-
Mark
Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.
(
- Contribution to journal › Article
- 2008
-
Mark
Role of DARPP-32 in Breast Cancer Cell Signalling and Migration
(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1.
(
- Contribution to journal › Article
- 1998
-
Mark
High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
(
- Contribution to journal › Article